Search

everythinglearnresearchcommunity

for

Search:↓

EGFR and MEK inhibitors reduce PD-L1 in hair follicles, possibly causing inflammation.

Five molecular elements identified as potential future targets for hair loss therapy.

Tofacitinib and adalimumab are promising treatments for cicatricial alopecia with few side effects.

Long-term finasteride use doesn't change bone density or metabolism.

Baricitinib helps grow eyebrows and eyelashes in severe alopecia areata patients.

Tofacitinib helped regrow hair in patients with alopecia, with few side effects.

Certain cancer drugs can cause skin issues like rashes and itching.

Using finasteride or dutasteride does not increase the risk of male breast cancer.

EGFR-TKIs can cause significant skin, nail, and organ side effects.

New treatments for cancer and skin disorders show promise in disrupting harmful cell interactions and promoting hair growth.

Sirolimus effectively reduces lesions and improves quality of life in Blue Rubber Bleb Nevus Syndrome with manageable side effects.

5α-reductase inhibitors lower overall prostate cancer risk but not high-grade cancer risk; longer-term screening and new treatments show promise.

Alisertib was found to be an effective and tolerable treatment for children with recurrent brain tumors.

Continuous baricitinib is needed to keep hair regrowth in severe alopecia areata.

New findings suggest the protein linked to Birt–Hogg–Dubé syndrome is important in cell signaling and could affect treatment understanding.

Taking 5-alpha reductase inhibitors does not increase the risk of breast cancer in men.

A balanced approach using dutasteride and Serenoa repens can improve hair transplant success by protecting follicles and minimizing side effects.

Certain gene patterns in breast cancer are linked to how active hormone receptors are and could affect patient survival.

Skin side effects from EGFR inhibitor cancer treatment can be managed effectively, often without stopping the medication.

Tofacitinib helped some young children with severe hair loss grow their hair back without bad side effects.

Blocking mTORC1 activity with rapamycin could help increase hair pigmentation and growth, potentially reversing gray hair.

New research is needed to create better drugs that block the enzyme responsible for conditions like male baldness and prostate enlargement.

Finasteride helps female-pattern hair loss.

Boron neutron capture therapy for head and neck cancer can cause side effects like mouth sores and skin irritation, which vary depending on where the treatment is aimed.

The document concludes that targeting the androgen receptor may be a promising breast cancer treatment, especially for certain types.

Oral JAK inhibitors improved alopecia areata by modulating immune responses and boosting hair growth.

Chemoprevention can significantly lower cancer risks and needs more research and collaboration.

Tofacitinib partially improved hair regrowth in a patient with severe hair loss.